Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.57 |
| ▸ | MAPT | P10636 | 4/20 | 0.57 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21340743 | 0.73 | ALDH1A1 (0.53) | ALDH1A1MAPTRXFP1L3MBTL1TAAR1 | |
| SCHEMBL1757748 | 0.69 | NPC1 (0.47) | ALDH1A1MAPTRXFP1L3MBTL1GAA | |
| SCHEMBL22574714 | 0.64 | GAA (0.45) | ALDH1A1MAPTRXFP1L3MBTL1GAA | |
| SCHEMBL13938473 | 0.63 | NPC1 (0.46) | ALDH1A1MAPTRXFP1L3MBTL1GAA | |
| SCHEMBL21561630 | 0.63 | CA1 (0.48) | ALDH1A1MAPTKMT2ALMNAMEN1 | |
| SCHEMBL34468596 | 0.63 | LMNA (0.57) | ALDH1A1MAPTL3MBTL1GAAKMT2A | |
| SCHEMBL5201218 | 0.60 | SMYD3 (0.44) | ALDH1A1MAPTRXFP1L3MBTL1GAA | |
| SCHEMBL4151496 | 0.59 | CA1 (0.52) | ALDH1A1MAPTKMT2ALMNAMEN1 | |
| Succinimide SCHEMBL27555395 | 0.56 | MAPK1 (0.40) | ALDH1A1MAPTL3MBTL1GAAKMT2A | |
| SCHEMBL25408527 | 0.56 | KDM4E (0.42) | ALDH1A1MAPTGAAKMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190277833-A1 | ANTI-METHANOGENIC COMPOSITIONS | SYNTHETIC BIOLOGICS INC (US) | 2019-09-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190277833-A1 | ANTI-METHANOGENIC COMPOSITIONS | ME3, HSD17B10, OAT | ALDH1A1 1674/4885MAPT 4000/4885RXFP1 4200/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.